Thrombolysis increases the risk of persistent headache attributed to ischemic stroke: A prospective observational study
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Intravenous thrombolysis (IVT) for acute ischemic stroke may increase the risk of developing persistent poststroke headaches. Younger age, female sex, and posterior circulation infarcts were also associated with persistent headaches.
Area Of Science
- Neurology
- Stroke Medicine
- Headache Disorders
Background
- Persistent headache attributed to ischemic stroke (PHPIS) is a recognized complication.
- Intravenous thrombolysis (IVT) is a standard acute ischemic stroke treatment.
- The impact of IVT on PHPIS development is not well understood.
Purpose Of The Study
- To determine the incidence and clinical characteristics of persistent headaches after ischemic stroke.
- To compare PHPIS rates in patients who received IVT versus those who did not.
- To identify risk factors for developing persistent poststroke headaches.
Main Methods
- Prospective observational study in 5 stroke units in Wuhan, China.
- 234 patients received IVT, and 226 did not.
- 6-month follow-up using a structured questionnaire.
Main Results
- 12.0% of all patients developed persistent headaches.
- PHPIS prevalence was significantly higher in the IVT group (15.4%) compared to the non-IVT group (8.4%).
- Risk factors included younger age, female sex, posterior circulation infarct, and IVT administration.
Conclusions
- IVT may influence the occurrence of persistent poststroke headaches.
- Clinicians should consider IVT when evaluating patients with persistent headaches after stroke.
- Further research is needed to elucidate the underlying mechanisms.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.